Authors 🖊️
Henrik Albaek Jacobsen
Christina Faaborg Larimore
Christian Graugaard
Mikael Andersson
Lone Larsen
Morten Frisch

@dg.dk @aau.dk @aalborguh.rn.dk

Authors 🖊️
Adam Faye
Kristine Højgaard Allin
Gry Juul Poulsen
Tine Jess

@dg.dk @aau.dk @aalborguh.rn.dk

PhD student Stine Kjærsgaard Hansen presented a poster of her work on autoimmune liver disease in IBD.

See you next year!

... between IBD and other immune-mediated diseases. Assistant professor Alonzo Alfaro Nunez and PhD student Mads Lie gave presentations on fecal DNA screening for early detection of colorectal cancer and phenotypical changes in pediatric IBD at diagnosis, respectively.

Research Associate Mette Julsgaard delivered a talk on pregnancy and infant outcomes following in-utero exposure to JAK inhibitors in women with inflammatory bowel disease (IBD). Post-doctoral fellow Marie Vibeke Vestergaard shared the findings of her study exploring associations ...

Thank you to the assessment committee; Professor Christina Brock from Aalborg University, Lecturer Ebbe Langholz from University of Copenhagen, and Senior Researcher Ignacio Catalan Serra from NTNU.

@dg.dk @aau.dk @aalborguh.rn.dk

These findings highlight that molecular processes underlying IBD may be detectable long before clinical onset and may also contribute to increased cancer risk later in life.

... 2) an increased risk of anorectal cancer in patients with fistulising Crohn’s disease based on nationwide register data, and 3) distinct metabolomic profiles in serum years before IBD diagnosis, some predictive of later disease through machine learning.

During her three years of research, Dr. Lemser focused on cancer risk and molecular alterations in IBD and found 1) an increased risk of cancer in pediatric-onset IBD from systematic review and meta-analysis ...

...
Ishtiaq Ahmed
Kishore Kumar Chitra Kumar
Laurette L Bukasa
Tine Jess
Saeed H Al Marzooqi
Talha A Malik
Mohammed Nabil Quraishi

@dg.dk @aau.dk @aalborguh.rn.dk

Our findings reiterate the need for early and effective intervention.

Authors 🖊️
Hosameldin Abdelrahman Ahmed
Mohamed Nasir Alzaabi
Thaer Khaleel Swaid
Shaima Wasim Khan, MD
Ameirah Badr Abdullah Al Ali
Khalifa Al Tenaiji
Maryam A Alahmad
Nadeen Mamon Omar
Enas Fouad Ahmed
Ibrahim Al Hosani
...

The study provides the most detailed look at IBD in the UAE to date. Between 2002 and 2024, a nearly 13-fold increase in new IBD diagnoses was observed, with a significant number of Crohn’s disease patients presenting with an aggressive form of the disease at diagnosis.

@dg.dk

@aau.dk

@aalborguh.rn.dk

He found 1) that existing evidence can be structured into a three-phase model of disease development – at-risk, initiation/expansion, and clinical onset, 2) subtle cytokine changes (IL-4, IL-17A) in very early-onset pediatric IBD, and 3) 25 metabolites at birth associated with later IBD.

@dg.dk @aau.dk @aalborguh.rn.dk

She found 1) preclinical changes in common blood samples up to 8 years before diagnosis, 2) genetic factors linked not only to disease onset but also to severity of disease course, and 3) 8 distinct patient trajectories based on non-invasive inflammatory markers, replicated across 2 European cohorts